We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×

Home > News > Testing

CW Analytical Announces State of The Art Microbiology Program

Published: Feb 15, 2018   

Complete the form below and we will email you a PDF version of "CW Analytical Announces State of The Art Microbiology Program "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Analytical Cannabis?

Analytical Cannabis Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

CW Analytical Announces State of The Art Microbiology Program

CW Analytical labs has expanded its capabilities to offer what they claim is the most comprehensive microbiological testing program in the Cannabis industry.


With a fusion of modern and classic microbiological techniques, CW Analytical now offers their California clients selective plating, biochemical profiling, protein fingerprinting, DNA-based assays, and morphological analyses. With these technologies, the California Cannabis community will not only meet, but also surpass current and future regulatory requirements.


"CW Analytical is proud to establish itself as the preeminent microbiology lab in the industry," says Robert Martin, Ph.D, CEO of CW Analytical. "It's time we begin understanding the microbiological implications of this alternative medicine and recreational product. These technologies will enable CW Analytical's clients to produce and commercialize the cleanest Cannabis available."


Salmonella sp. Analysis


Since 2015, CW Analytical has tested Cannabis and Cannabis products for Salmonella sp. as a required quality assurance measure, adopted first by the City of Berkeley and now by the California Bureau of Cannabis Control.


To date, the laboratory has examined over 16,000 samples for this pathogenic bacterium, utilizing methods from the FDA Bacteriological Analytical Manual, and has yet to observe any confirmed positive contamination of Salmonella sp. on Cannabis.


"Our team employs an appropriately sophisticated method of screening for Salmonella sp. that allows us to properly detect, enrich, isolate, and recognize problematic presumptive and false positives that plague our industry," says Charisse Mae MacDula, CW Analytical Microbiologist. "As regulations evolve, it's important that quality assurance focuses on measures that pose legitimate concerns for consumers."


While these microbiological testing processes can sometimes delay the release of a complete laboratory report, it is often imperative to the integrity of the analysis.


"Scientifically valid methods for the detection and confirmed identification of bacterial and fungal organisms often require resuscitation and enrichment steps, isolation procedures and incubation periods that cannot be avoided or shortened," states Emily Savage, CW Analytical's Microbiology Lab Manager. "We will continue to hold the integrity of the data of highest importance. The standards of excellence we employ in identifying and confirming contaminants should be commonplace in any reputable laboratory."


This article has been republished from materials provided by CW Analytical. Note: material may have been edited for length and content. For further information, please contact the cited source.

 

Like what you just read? You can find similar content on the topic tag shown below.

Testing

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter

 
Advertisement